Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis

E Gorelik, R Masarwa, A Perlman, V Rotshild, M Abbasi… - Drug safety, 2019 - Springer
Introduction Several fluoroquinolone antibiotics have been associated with cardiac adverse
effects, leading to the withdrawal of some of these agents from the market. Cardiac side …

From 'OPAT'to 'COpAT': implications of the OVIVA study for ambulatory management of bone and joint infection

RA Seaton, ND Ritchie, F Robb… - Journal of …, 2019 - academic.oup.com
Bone and joint infection contributes significantly to clinical activity within outpatient
parenteral antimicrobial therapy (OPAT) services. The OVIVA (oral versus intravenous …

The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies

X Liu, W Wang, Z Tan, X Zhu, M Liu, R Wan, K Hong - Nutrition journal, 2019 - Springer
Background The relationship between serum vitamin D and atrial fibrillation (AF) or
postoperative atrial fibrillation (POAF) in patients undergoing coronary artery bypass graft …

Oral fluoroquinolones and risk of mitral and aortic regurgitation

M Etminan, M Sodhi, S Ganjizadeh-Zavareh… - Journal of the American …, 2019 - jacc.org
Background: Recent studies have linked fluoroquinolones (FQs) to cardiac adverse events,
including aortic dissection and aneurysm. To date, whether FQs can increase the risk of …

Adverse effects of fluoroquinolones: a retrospective cohort study in a South Indian tertiary healthcare facility

B Mathews, AA Thalody, SS Miraj, V Kunhikatta, M Rao… - Antibiotics, 2019 - mdpi.com
The Food and Drug Administration (FDA) safety review revealed that the use of
fluoroquinolones (FQs) is linked with disabling and potentially permanent serious adverse …

Resting heart rate and the risk of atrial fibrillation a dose-response analysis of cohort studies

X Liu, N Guo, W Zhu, Q Zhou, M Liu, C Chen… - International heart …, 2019 - jstage.jst.go.jp
In a previous meta-analysis, it was demonstrated that the resting heart rate (RHR) is a
potential risk factor for atrial fibrillation (AF). However, the results of that meta-analysis were …

Investigation of cardiotoxic effects of marbofloxacin.

D Coșkun, B Dik, Y Korkmaz, R Canbar, A Er, E Yazar - 2019 - cabidigitallibrary.org
Aim: The primary objective of the present research is to determine the cardiotoxic effect of
marbofloxacin by measuring of serum troponin I, creatine kinase-MB (CK-MB), lactate …

Фторхинолоновые антибиотики: безопасность применения на примере ципрофлоксацина

НВ Молчан, ЮА Смирнова, НЮ Вельц… - Безопасность и риск …, 2019 - cyberleninka.ru
В связи с повторяющимися сообщениями о побочных эффектах при применении
антибиотиков фторхинолоновой группы эти препараты вновь и вновь становятся …

Fluoroquinolone use and serious arrhythmias: a nationwide case-crossover study

L Porta, MG Lee, WT Hsu, TC Hsu, TY Tsai, CC Lee - Resuscitation, 2019 - Elsevier
Aim Fluoroquinolones have been associated with life-threatening ventricular arrhythmias
and even sudden cardiac death. We aimed to assess the temporal relationship of …

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin

NV Molchan, YA Smirnova, NY Velts… - Safety and Risk of …, 2019 - risksafety.ru
Due to repeated reports of adverse effects with the use of fluoroquinolone antibiotics, these
drugs become over and over again the object of the close attention of pharmacovigilance …